Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes-Reference-Cited by-同舟云学术

Association of Pretreatment With P2Y12 Receptor Antagonists Preceding Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes With Outcomes

Published:2020-10-01 Issue:10 Volume:3 Page:e2018735
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Dworeck Christian¹,Redfors Björn¹,Angerås Oskar¹,Haraldsson Inger¹,Odenstedt Jacob¹,Ioanes Dan¹,Petursson Petur¹,Völz Sebastian¹,Persson Jonas²,Koul Sasha³,Venetsanos Dimitrios⁴,Ulvenstam Anders⁵,Hofmann Robin⁶,Jensen Jens⁷,Albertsson Per¹,Råmunddal Truls¹,Jeppsson Anders⁸,Erlinge David³,Omerovic Elmir¹

Affiliation:

1. Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden

2. Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden

3. Department of Cardiology, Skåne University Hospital, Lund, Sweden

4. Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden

5. Department of Cardiology, Östersund Hospital, Östersund, Sweden

6. Division of Cardiology, Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

7. Department of Clinical Science and Education, Karolinska Institutet, Cardiology Capio Sankt Goran Hospital, Stockholm, Sweden

8. Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2771118/dworeck_2020_oi_200664_1600876647.78636.pdf

Reference27 articles.

1. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).;Hamm;Eur Heart J,2011

2. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.;Amsterdam;J Am Coll Cardiol,2014

3. Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention.;Steinhubl;J Am Coll Cardiol,2006

4. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.;Steinhubl;JAMA,2002

5. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.;Mehta;Lancet,2001

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ¿El pretratamiento en los SCASEST recomendado por las guías es lo que refleja el mundo real?;Archivos de Cardiología de México;2024-01-10

2. Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction;JACC: Cardiovascular Interventions;2024-01

3. 2023 ESC Guidelines for the management of acute coronary syndromes;European Heart Journal: Acute Cardiovascular Care;2023-09-22

4. European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey;International Journal of Cardiology;2023-09

5. 2023 ESC Guidelines for the management of acute coronary syndromes;European Heart Journal;2023-08-25